Bloomberg BNA’s Corporate Law & Accountability Report is available on the Corporate Law Resource Center. This news service keeps corporate practitioners informed of legal developments of...
Aug. 16 — Medizone International Inc. shareholders may get to vote on a proposal setting an age limit for the company's directors ( Medizone International Inc., SEC No-Action Letter, 8/9/16).
The Securities and Exchange Commission Division of Corporation Finance, in an Aug. 9 letter, said it was unable to concur that the proposal could be omitted from the company's proxy materials under a rule that sets the deadline for submitting shareholder proposals if the company doesn't hold an annual meeting the previous year.
Under 1934 Securities Exchange Act Rule 14a-8(e)(2), the deadline for proposals under such circumstances is a “reasonable time” before the company begins to print and send its proxy materials. The company argued that when it received the proposal, it had already finalized its form of proxy card.
The resolution submitted by shareholder Peter Gaide requested amendments to Medizone's bylaws that would cap the age at which an individual could serve as a director or officer. Gaide argued that his proposal was timely because Medizone was notified of it within four days of the company filing its preliminary proxy.
“If [Medizone] Counsel’s argument is upheld, they could just as easily have ‘finalized’ the proxy materials one day following the filing of the preliminary materials and thereby exclude any shareholder proposals,” he wrote.
To contact the reporter on this story: Michael Greene in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Yin Wilczek at email@example.com
The SEC's no-action letter is available at https://www.sec.gov/divisions/corpfin/cf-noaction/14a-8/2016/petergaide080916-14a8.pdf.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)